Every dated change on the records linked to Early-stage classical Hodgkin lymphoma (stage I to II), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Two cycles of ABVD with 20 Gy as effective as four cycles with 30 Gy (five-year freedom from treatment failure 91.
A milestone in how this cancer is treated.